GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment

Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Sanofi India Ltd
Sanofi India to Host Investor Call for Q1/H1 FY27 Unaudited Financial Results
RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 23 Jul 2026, 11:30 AM IST  ·  BSE ID: 68bef37d-bd00-4956-bf9d-e558ad8ea454
View Original BSE Filing (PDF)
💡
In Simple Terms
Sanofi India will hold a meeting for investors on August 5, 2026, to discuss its financial results for April-June 2026.
🤖 AI Summary
  • Sanofi India announced an investor/analysts call on August 5, 2026, for Q1 and H1 FY27 unaudited results.
  • The call is scheduled from 4:00 p.m. to 5:00 p.m. IST, accessible via universal and international dial-in.
  • Pre-registration is mandatory, closing at 12:00 p.m. IST on August 5, 2026, to participate.
  • Investors can view the presentation and engage with company management during the call.
👥 What This Means For Shareholders
✅
Action Required
Shareholders interested in the Q1 and H1 FY27 unaudited financial results should pre-register for the investor/analysts call by 12:00 p.m. IST on August 5, 2026.
👤
Who Is Affected
All existing shareholders and potential investors are affected by this announcement, as it facilitates direct communication and understanding of the company's performance and outlook.
🔍
Management Signal
The decision to hold an investor call signals management's commitment to transparency and direct communication with the investment community regarding financial performance.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Investor/analysts call on August 5, 2026 — attend for Q1/H1 FY27 financial details.
Official release of unaudited financial results for Q1 and H1 FY27.
Management commentary during the investor call for business updates.
LOW RISK The filing is a procedural announcement for an investor call and presents no inherent risks.
💡 Investor Takeaway
Sanofi India will host an investor/analysts call on Wednesday, August 5, 2026, from 4:00 p.m. to 5:00 p.m. (IST) to provide an update on its unaudited financial results for the quarter and half-year ended June 30, 2026.
📅 Company Track Record
Sanofi India's Q4 FY26 unaudited results showed its insulin portfolio grew 19% YoY to ₹4,723 Million revenue. Total revenue declined 11.6% during the same period, primarily due to partnership transitions. The board meeting to approve Q4 FY26 results was held on April 28, 2026.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is Sanofi India's investor/analysts call scheduled?
Sanofi India's investor/analysts call is scheduled for Wednesday, August 5, 2026, from 4:00 p.m. to 5:00 p.m. (IST).
What will be discussed during the Sanofi India investor call?
The investor call will provide an update on Sanofi India's unaudited financial results for the quarter and half year ended June 30, 2026.
Is pre-registration required for the Sanofi India investor call?
Yes, pre-registration is required for the Sanofi India investor call and will remain open until 12:00 p.m. IST on August 5, 2026.
What are the universal dial-in numbers for the Sanofi India investor call?
The universal dial-in numbers for the Sanofi India investor call are +91 22 6280 1191 and +91 22 7115 8075.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.